|
Quotes & Info
|
| PEX > SEC Filings for PEX > Form 8-K on 11-May-2009 | All Recent SEC Filings |
11-May-2009
Other Events
Apex Bioventures Acquisition Corp. (the "Company") received a notice dated February 10, 2009 from the NYSE Amex LLC (the "Exchange") stating that the Company is not in compliance with one of the requirements for continued listing on the Exchange. Specifically, the Exchange advised that the Company is not in compliance with Section 704 of the Exchange's Company Guide because the Company did not hold an annual meeting during calendar year 2008. The Company was afforded the opportunity to submit to the Exchange a plan of compliance and on March 6, 2009 submitted its plan to the Exchange.
On May 8, 2009, the Exchange notified the Company that it accepted the Company's plan of compliance and granted the Company an extension until August 11, 2009 to regain compliance with the continued listing standards. The Company will be subject to periodic review by the Exchange staff during the extension period. Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the Exchange.
On May 11, 2009, the Company issued a press release disclosing its receipt of the above summarized notice of extension from the Exchange. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
|
|